118 related articles for article (PubMed ID: 38664232)
21. Oligomerization of Mutant p53 R273H is not Required for Gain-of-Function Chromatin Associated Activities.
Annor GK; Elshabassy N; Lundine D; Conde DG; Xiao G; Ellison V; Bargonetti J
Front Cell Dev Biol; 2021; 9():772315. PubMed ID: 34881245
[TBL] [Abstract][Full Text] [Related]
22. Coactivator function of positive cofactor 4 (PC4) in Sp1-directed luteinizing hormone receptor (LHR) gene transcription.
Liao M; Zhang Y; Kang JH; Dufau ML
J Biol Chem; 2011 Mar; 286(9):7681-91. PubMed ID: 21193408
[TBL] [Abstract][Full Text] [Related]
23. Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells.
Kanagasabai R; Krishnamurthy K; Druhan LJ; Ilangovan G
J Biol Chem; 2011 Sep; 286(38):33289-300. PubMed ID: 21784846
[TBL] [Abstract][Full Text] [Related]
24. p53 mutants induce transcription of NF-κB2 in H1299 cells through CBP and STAT binding on the NF-κB2 promoter and gain of function activity.
Vaughan CA; Singh S; Windle B; Sankala HM; Graves PR; Andrew Yeudall W; Deb SP; Deb S
Arch Biochem Biophys; 2012 Feb; 518(1):79-88. PubMed ID: 22198284
[TBL] [Abstract][Full Text] [Related]
25. Human Positive Coactivator 4 Affects the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma via the mTOR/P70s6k Signaling Pathway.
Su X; Yang Y; Ma L; Luo P; Shen K; Dai H; Jiang Y; Shuai L; Liu Z; You J; Min K; Shi C; Chen Z
Onco Targets Ther; 2020; 13():12213-12223. PubMed ID: 33273827
[TBL] [Abstract][Full Text] [Related]
26. The C-terminus of Gain-of-Function Mutant p53 R273H Is Required for Association with PARP1 and Poly-ADP-Ribose.
Lundine D; Annor GK; Chavez V; Maimos S; Syed Z; Jiang S; Ellison V; Bargonetti J
Mol Cancer Res; 2022 Dec; 20(12):1799-1810. PubMed ID: 36074101
[TBL] [Abstract][Full Text] [Related]
27. Interaction of promyelocytic leukemia/p53 affects signal transducer and activator of transcription-3 activity in response to oncostatin M.
Lim J; Choi JH; Park EM; Choi YH
Korean J Physiol Pharmacol; 2020 May; 24(3):203-212. PubMed ID: 32392911
[TBL] [Abstract][Full Text] [Related]
28. Functional interaction between the HIV transactivator Tat and the transcriptional coactivator PC4 in T cells.
Holloway AF; Occhiodoro F; Mittler G; Meisterernst M; Shannon MF
J Biol Chem; 2000 Jul; 275(28):21668-77. PubMed ID: 10887206
[TBL] [Abstract][Full Text] [Related]
29. Abrogation of wild-type p53-mediated transactivation is insufficient for mutant p53-induced immortalization of normal human mammary epithelial cells.
Cao Y; Gao Q; Wazer DE; Band V
Cancer Res; 1997 Dec; 57(24):5584-9. PubMed ID: 9407971
[TBL] [Abstract][Full Text] [Related]
30. Nonhistone human chromatin protein PC4 is critical for genomic integrity and negatively regulates autophagy.
Sikder S; Kumari S; Mustafi P; Ramdas N; Padhi S; Saha A; Bhaduri U; Banerjee B; Manjithaya R; Kundu TK
FEBS J; 2019 Nov; 286(22):4422-4442. PubMed ID: 31169983
[TBL] [Abstract][Full Text] [Related]
31. Gb3-cSrc complex in glycosphingolipid-enriched microdomains contributes to the expression of p53 mutant protein and cancer drug resistance via β-catenin-activated RNA methylation.
Roy KR; Uddin MB; Roy SC; Hill RA; Marshall J; Li YT; Chamcheu JC; Lu H; Liu YY
FASEB Bioadv; 2020 Nov; 2(11):653-667. PubMed ID: 33205006
[TBL] [Abstract][Full Text] [Related]
32. Mutant p53 disrupts MCF-10A cell polarity in three-dimensional culture via epithelial-to-mesenchymal transitions.
Zhang Y; Yan W; Chen X
J Biol Chem; 2011 May; 286(18):16218-28. PubMed ID: 21454711
[TBL] [Abstract][Full Text] [Related]
33. Interaction between the transactivation domain of p53 and PC4 exemplifies acidic activation domains as single-stranded DNA mimics.
Rajagopalan S; Andreeva A; Teufel DP; Freund SM; Fersht AR
J Biol Chem; 2009 Aug; 284(32):21728-37. PubMed ID: 19525231
[TBL] [Abstract][Full Text] [Related]
34. Butein inhibits cancer cell growth by rescuing the wild-type thermal stability of mutant p53.
Song B; Wang J; Ren Y; Su Y; Geng X; Yang F; Wang H; Zhang J
Biomed Pharmacother; 2023 Jul; 163():114773. PubMed ID: 37156116
[TBL] [Abstract][Full Text] [Related]
35. Redox-mediated upregulation of hepatocyte iNOS transcription requires coactivator PC4.
Marroquin CE; Wai PY; Kuo PC; Guo H
Surgery; 2005 Jul; 138(1):93-9. PubMed ID: 16003322
[TBL] [Abstract][Full Text] [Related]
36. Positive cofactor 4 (PC4) contributes to the regulation of replication-dependent canonical histone gene expression.
Brzek A; Cichocka M; Dolata J; Juzwa W; Schümperli D; Raczynska KD
BMC Mol Biol; 2018 Jul; 19(1):9. PubMed ID: 30053800
[TBL] [Abstract][Full Text] [Related]
37. Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs.
Puca R; Nardinocchi L; Porru M; Simon AJ; Rechavi G; Leonetti C; Givol D; D'Orazi G
Cell Cycle; 2011 May; 10(10):1679-89. PubMed ID: 21508668
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of a small molecule inhibitor of the transcriptional cofactor PC4 in prevention and treatment of non-small cell lung cancer.
Zhang Y; Pavlov A; Malik S; Chen H; Kim N; Li Z; Zhang X; DePamphilis ML; Roeder RG; Ge H
PLoS One; 2020; 15(3):e0230670. PubMed ID: 32231397
[TBL] [Abstract][Full Text] [Related]
39. Gain-of-Function Activity of Mutant p53 in Lung Cancer through Up-Regulation of Receptor Protein Tyrosine Kinase Axl.
Vaughan CA; Singh S; Windle B; Yeudall WA; Frum R; Grossman SR; Deb SP; Deb S
Genes Cancer; 2012 Jul; 3(7-8):491-502. PubMed ID: 23264849
[TBL] [Abstract][Full Text] [Related]
40. TopBP1 mediates mutant p53 gain of function through NF-Y and p63/p73.
Liu K; Ling S; Lin WC
Mol Cell Biol; 2011 Nov; 31(22):4464-81. PubMed ID: 21930790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
